Valiquette also increased his earnings per share (EPS) estimates for Cardinal Health (NYSE:CAH), raising the fiscal year 2025 forecast from $7.90 to $7.95 and the fiscal year 2026 projection from $8 ...
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...
Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...
Only one more half stands between Stanford and the win they were favored to collect coming into this evening. They have ...
Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target was ...
Despite his disappointment, Cardinal Dolan expressed hope that Vance’s comments were uncharacteristic and not reflective of ...
The Cardinal STEM Academy program with Green Valley Elementary went to East Tennessee university this past Saturday and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback